Frontlight ResearchEarly access
Trial site
Petz Aladar Egyetemi Oktato Korhaz
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Bipolar disorder1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Hodgkin lymphoma1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Stroke1 trial
- and 1 more
- Phase
- Phase 310 trials
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Bristol-Myers Squibb1 trial
- Genmab1 trial
- Grifols Therapeutics LLC1 trial
- Merck Sharp & Dohme LLC1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bipolar disorder1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Hodgkin lymphoma1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026